Passage Bio initiated overweight at Raymond James; expects a de-risking event this year
dinn/iStock via Getty Images
- Passage Bio (NASDAQ:PASG) is trading ~3.4% higher
in the post-market after Raymond James started the coverage of the stock with an overweight rating and a price target of $29.00 per share to imply a premium of ~119.0% to the…